163 results on '"Del Papa, Beatrice"'
Search Results
2. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models
3. NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
4. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
5. GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations
6. Clinical-Grade–Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell–Dependent Graft-versus-Leukemia Effect in Murine Models
7. NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.
8. Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
9. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
10. T regulatory cell separation for clinical application
11. New mechanism of lymphoma-induced bone marrow aplasia
12. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
13. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation
14. NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion
15. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
16. NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
17. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35
18. Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
19. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation
20. Interleukin-7–Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population
21. Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line
22. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
23. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
24. Adoptive Immunotherapy with Regulatory and Conventional T Cells in Haploidentical Transplantation Primes Dendritic Cells to Promote T Cell Alloreactivity in the Bone Marrow and Tolerance in the Periphery
25. NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells
26. NOTCH and Graft-Versus-Host Disease
27. Catalase prevents DNA damage and cationic current activation by silver nanoparticles in U251 human glioblastoma cell line
28. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
29. NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells
30. Ibrutinib Treatment of a Patient with Relapsing Chronic Lymphocytic Leukemia and Sustained Remission of Richter Syndrome
31. The radiosensitizer silver nanoparticles effects are prevent to ion channel blocker DIDS in U251 human glioblastoma cell line
32. GATA1epigenetic deregulation contributes to the development of AML with NPM1and FLT3-ITD cooperating mutations
33. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction
34. NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells
35. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
36. Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A
37. Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23
38. Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment
39. IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment
40. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
41. A novelNOTCH1PEST domain mutation in a case of chronic lymphocytic leukemia
42. γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation
43. Transformation by Retroviral Vectors of Bone Marrow-Derived Mesenchymal Cells Induces Mitochondria-Dependent cAMP-Sensitive Reactive Oxygen Species Production
44. Mesenchymal cells recruit and regulate T regulatory cells
45. T Cell Pathway Deficiencies in Chronic Lymphocityc Leukemia: Partial Restoration with OKT3/IL-2 Activation.
46. Engineering Mesenchymal Cells with Interleukin 7 Gene: In Vitro Effects on Naive T Cell Population.
47. A Microelectronic DNA Chip Detects the V617F JAK-2 Allelic Ratio in Myeloproliferative Disorders.
48. Human Mesenchymal Cells Regulates Naive and Memory T Regulatory Cells.
49. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction.
50. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.